Achromobacter xylosoxidans (AX) is known for intrinsic resistance to disinfectants. Günther, et al. (2016) report on how their laboratory routine surveillance system detected an unexpected rise in AX bloodstream infections in a 2,200-bed hospital. An epidemiological investigation was conducted to find the source and disrupt further transmission.
Outbreak cases were defined as patients with at least one positive blood culture positive for AX from May 2014 to May 2015. Medical records were reviewed, affected wards, as well as the microbiology laboratory were audited. Additionally, microbiologic culture and biofilm staining for suspected antiseptic reusable tissue dispensers were performed, and isolated AX strains were typed using RAPD PCR and PFGE.
During the outbreak period, AX were isolated from blood cultures from 26 patients. The retrospective cohort study did not reveal common risk factors. The clinical features of the case patients suggested a pseudobacteremia. The reusable tissue dispensers containing Incidin® Plus solution product were found to be contaminated with biofilm-forming AX. Typing of the isolates revealed that blood culture isolates were identical with the strains found in the dispensers.
After changing the usage of the product to single-use and educating staff, the outbreak was terminated. Contamination of dispensers occurred due to insufficient reprocessing, since biofilm disrupting steps were not included in the process.
Reference: Günther F, Merle U, Frank U, Gaida MM and Mutters NT. Pseudobacteremia outbreak of biofilm-forming Achromobacter xylosoxidans – environmental transmission. BMC Infectious Diseases. 2016;16:584.
The Evolution of Health Care Environmental Hygiene: A Long Overdue Shift in Infection Control
September 5th 2024This new column, Clean Hospital with Alexandra Peters, PhD, explores advancements in health care environmental hygiene, highlighting its growing recognition as a key component of infection prevention and honoring pioneers like Professor Stephanie Dancer.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Infection Intel: Augmenting SHIELD WALL Modular Containment Systems by Abatement Technologies
August 8th 2024Jackie Otero, senior territory sales representative at Abatement Technologies, discusses the SHIELD WALL modular containment system by Abatement Technologies, highlighting its quick assembly, durability, noise reduction, and benefits in maintaining indoor air quality in health care settings.
Phage Therapy: The Future of Bacterial Infection Treatment?
August 7th 2024Rising antibiotic resistance necessitates exploring phage therapy as an alternative. Despite historical sidelining, phages show promise in treating various infections, but regulatory, safety, and resistance challenges remain.